BioHistory Moment: FDA requested help in removing a hazardous product, "X-33 Water Repellent," from the market
On August 30, 1964, the FDA asked state and local health and safety officials for help in removing "X-33 Water Repellent"
from the market. The extremely flammable product had caused three deaths and more than 30 injuries through flash explosions,
in many cases while it was being used in home basements to waterproof masonry.
Federal oversight of consumer products such as X-33 and many other items used in the home was transferred to the newly
created Consumer Product Safety Commission in 1973. One class of consumer products still regulated by the FDA is
radiation-emitting products.
 More...
Learn about Seattle's Life Science Incubator Facility
Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with
modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical
space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington,
the Fred Hutchinson Cancer Research Center, and more.
Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in Maine, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- Celsion receives SBIR grant to expand Its technology platform Celsion has been awarded a Phase I Small SBIR grant from the NIH, to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer". This funding will support the Company's efforts to develop its proprietary heat-activated liposomal technology in combination with carboplatin.
Celsion Corporation September 03, 2010
- Celgene officially notified of ANDA filing for REVLIMID(R) Celgene announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the FDA. The application requests authorization to manufacture and market generic versions of REVLIMID(R) in the U.S.
Celgene Corporation September 03, 2010
- Tibotec seeks European Marketing Authorization for once-daily HIV treatment TMC278 Tibotec Pharmaceuticals announced its submission of a Marketing Authorisation Application to the European Medicines Agency for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor for the treatment of HIV.
Tibotec Pharmaceuticals September 03, 2010
- European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
- New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Maine's BioHistory
Why is there a life science industry in Maine? Is the industry
growing? What do other states have?
Through Maine BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in Maine.
More...
BioEvolution Posters
More...
August: National Immunization Awareness Month
The goal of National Immunization Awareness Month (NIAM) is to increase awareness about immunizations across the life
span, from infants to the elderly.
Immunization is one of the most significant public health achievements of the 20th century. Vaccines have
eradicated smallpox, eliminated wild poliovirus in the U.S. and significantly reduced the number of cases of measles,
diphtheria, rubella, pertussis and other diseases. But despite these efforts, people in the U.S. still die from these
and other vaccine-preventable diseases.
More...
BioFact
(1988) - Canadian scientists discover that bacteria taken from the bodies of two explorers frozen in the Arctic since 1846 are resistant to modern antibiotics. This challenges current dogma that resistance to antibiotics is caused only by their overuse.
It's a Small World
|
| |
Yersinia Pestis (Fluorescent)
| |
Science Quote
"An experiment is a question which science poses to Nature, and a measurement is the recording of Nature's answer.\"
| - |
Max Planck, German physicist, (Nobel Laureate, 1918)
|
|
(1858-1947)
|
|
